neoX: neoX Biotech closes US$30 million Series A round
The funds will be used to tackle undruggable targets BEIJING, Feb. 9, 2021 /PRNewswire/ -- neoX Biotech, a next-generation biotech company specializing in computational design for novel drug resea...
Read full article »
Co-Founder & CEO
Michael Chen
NeoX Biotech is a China-based biotechnology company that combines AI with biophysics for the discovery and development of macromolecular drugs to treat cancer.
Read more